Liraglutide from Suzhou Tianma Pharma

Suzhou Tianma Pharmaceutical Group Co., Ltd. is in Suzhou, Jiangsu Province. The company was established in 1993 and is a technology-based enterprise integrating biopharmaceuticals, cultural tourism real estate and foreign investment. It owns Suzhou Tianma Pharmaceutical Group Tianji Biopharmaceutical Co., Ltd., Jiangsu Pegasus Pharmaceutical Co., Ltd., Suzhou Sky Investment Development Co., Ltd., Suzhou Hanyuan Yacht Resort Hotel, Jinlitong Real Estate Co., Ltd., Suzhou Rongyi Da Commercial Management Co., Ltd., Shanghai Zihui Investment Management Co., Ltd., Suzhou Zihui Tianma Venture Capital and many other wholly-owned and joint-stock companies.

Suzhou Tianma Pharmaceutical Group has a registered capital of RMB 100 million. Since its establishment, the group has actively implemented the principles of industrialization, standardization, marketization and scale. It is committed...

Read full company description
Address: No. 199, Huayuan East Road, Mudu Town, Wuzhong District, , Suzhou
China
China Local time:

Specialization in Peptide and Small Molecule Drug Development

GMP-Compliant Manufacturing Focused on Sterile and Non-Sterile Production

New Manufacturing 59,500 m² Facility for Growing Demand

Our clients:

All API Buyers

Our services:

API
CDMO
CRO

Response time:

Producer

Produced in:

China

MOQ: -

  • GMP

  • CoA

  • MSDS

  • BSE/TSE

  • USDMF

  • EDMF/ASMF

  • JDMF

  • KDMF

Contact supplier

Replies quickly

Suzhou Tianma Pharma Liraglutide API Producer - 204656-20-2

Description:
Suzhou Tianma Pharma offers high-quality Liraglutide API, certified for compliance with international standards. Manufactured in China from 1993. Specialization in Peptide and Small Molecule Drug Development. GMP-Compliant Manufacturing Focused on Sterile and Non-Sterile Production. New Manufacturing 59,500 m² Facility for Growing Demand.

Product Details

Certifications
GMP, CoA, MSDS, BSE/TSE, USDMF, EDMF/ASMF, JDMF, KDMF compliant
Minimum Order Quantity
Produced in
China (Asia)
DrugBank ID
DB06655
CAS Number
204656-20-2
Unique Ingredient Identifier
839I73S42A
Raw Material Category
GLP1 agonists

Ordering Process

1. Inquiry Submission: Click "Send Inquiry" to connect directly with producer.

2. Requirement Specification: Outline your needs for tailored offers.

3. Quotation: Receive the best quote and terms exclusively through Pharmaoffer.

Additional Products

We offer 24 other Active Pharmaceutical Ingredients and excipients, showcasing our production and distribution capabilities.

Contact Us

Are you looking for Liraglutide API? Contact Suzhou Tianma Pharma by using the send inquiry button. We will respond quickly with pricing and terms exclusively through Pharmaoffer.

Please, provide enough information regarding your inquiry. Let us know whether you require Ph.Eur (EP), USP, BP, JP grade, whether you are looking for hydrochloride (HCl), base, or other specific product specifications. Additionally, please inform us if the API is intended for your own production, resale, or research purposes. Contact us to receive a quote, download certificates, and purchase the Liraglutide API

Suzhou Tianma Pharma


Suzhou Tianma Pharmaceutical Group Co., Ltd. is in Suzhou, Jiangsu Province. The company was established in 1993 and is a technology-based enterprise integrating biopharmaceuticals, cultural tourism real estate and foreign investment. It owns Suzhou Tianma Pharmaceutical Group Tianji Biopharmaceutical Co., Ltd., Jiangsu Pegasus Pharmaceutical Co., Ltd., Suzhou Sky Investment Development Co., Ltd., Suzhou Hanyuan Yacht Resort Hotel, Jinlitong Real Estate Co., Ltd., Suzhou Rongyi Da Commercial Management Co., Ltd., Shanghai Zihui Investment Management Co., Ltd., Suzhou Zihui Tianma Venture Capital and many other wholly-owned and joint-stock companies.

Suzhou Tianma Pharmaceutical Group has a registered capital of RMB 100 million. Since its establishment, the group has actively implemented the principles of industrialization, standardization, marketization and scale. It is committed to building a modern enterprise group with interactive capital operation and industrial management development. Through incremental investment, it actively seeks industrial expansion. It has formed a strategic pattern of distinct main business, comprehensive development and benign interaction with the help of precise investment in external industries.

Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Co., Ltd is one of the leading companies in the domestic peptide industry. We specialize in developing, producing and selling peptide drugs, including APls, small-volume injections (sterile), small-volume injections (non-sterile) and lyophilized powder injections. Meanwhile, we also provide customized services for peptide fragments and intermediates.